Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 1.820
-0.030 (-1.62%)
Last updated: Aug 26, 2026, 2:29 PM CET
Pentixapharm Holding AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.06 | 0.09 | 0.16 | 0.02 | 0.03 | 0.06 |
Other Revenue | 0.19 | 0.43 | 1.27 | 1.74 | - | 0 |
| 0.24 | 0.53 | 1.43 | 1.76 | 0.03 | 0.06 | |
Revenue Growth | -86.48% | -63.28% | -18.79% | 5590.32% | -49.18% | - |
Cost of Revenue | 5.41 | 6.92 | 3.78 | 0.05 | - | - |
Gross Profit | -5.17 | -6.39 | -2.35 | 1.71 | 0.03 | 0.06 |
Selling, General & Admin | 6.59 | 6.89 | 2.26 | 2.29 | 1.26 | 1.13 |
Other Operating Expenses | 2.35 | 2.85 | 2.72 | 5.36 | 0.83 | 0.47 |
Operating Expenses | 12.63 | 13.47 | 24.06 | 7.8 | 2.2 | 1.7 |
Operating Income | -17.8 | -19.86 | -26.41 | -6.09 | -2.17 | -1.64 |
Interest Expense | -0.09 | - | -0.1 | -0.18 | - | -0 |
Interest & Investment Income | 0.2 | 0.35 | 0.57 | 0.13 | - | - |
Earnings From Equity Investments | - | - | - | - | 1.4 | -0.09 |
Currency Exchange Gain (Loss) | - | - | 0.01 | -0.07 | -0 | -0 |
EBT Excluding Unusual Items | -17.82 | -19.51 | -25.92 | -6.21 | -0.78 | -1.73 |
Gain (Loss) on Sale of Assets | - | - | 6.7 | - | - | - |
Other Unusual Items | - | - | 1.72 | - | - | - |
Pretax Income | -17.82 | -19.51 | -17.5 | -6.21 | -0.78 | -1.73 |
Income Tax Expense | -2.79 | -3 | -4.44 | 1.43 | 1.18 | 0.76 |
Net Income | -15.03 | -16.51 | -13.06 | -7.64 | -1.96 | -2.49 |
Net Income to Common | -15.03 | -16.51 | -13.06 | -7.64 | -1.96 | -2.49 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 25 | 25 | 25 | 22 | - | - |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 22 | - | - |
Shares Change | - | - | 14.21% | - | - | - |
EPS (Basic) | -0.61 | -0.67 | -0.53 | -0.35 | - | - |
EPS (Diluted) | -0.61 | -0.67 | -0.53 | -0.35 | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -14.62 | -18.6 | -7.35 | -2.81 | -6.24 | -4.1 |
Free Cash Flow Per Share | -0.59 | -0.75 | -0.30 | -0.13 | - | - |
Gross Margin | - | - | -164.01% | 96.94% | 100.00% | 100.00% |
Operating Margin | -7356.61% | -3775.66% | -1843.35% | -345.24% | -7006.45% | -2690.16% |
Profit Margin | -6211.57% | -3138.97% | -911.62% | -433.05% | -6325.81% | -4085.25% |
Free Cash Flow Margin | -6040.50% | -3535.74% | -513.26% | -159.47% | -20141.94% | -6726.23% |
EBITDA | -17.58 | -19.6 | -26.34 | -5.94 | -2.06 | -1.54 |
D&A For EBITDA | 0.22 | 0.26 | 0.07 | 0.15 | 0.11 | 0.11 |
EBIT | -17.8 | -19.86 | -26.41 | -6.09 | -2.17 | -1.64 |